Verily · 4 weeks ago
Software Engineer III, Viewpoint
Verily is a subsidiary of Alphabet focused on changing healthcare management through a data-driven approach. The Software Engineer III will be responsible for all aspects of the software development life cycle, collaborating with cross-functional teams to deliver high-quality software solutions for clinical research sites.
AnalyticsEnterprise SoftwareHealth CareInformation Technology
Responsibilities
Design, develop, test, deploy, maintain and improve software
Manage individual project priorities, deadlines and deliverables
Collaborate with cross-functional teams to deliver a high quality, FDA regulated software
Qualification
Required
BS degree in Computer Science, Computer Engineering or related technical field, or equivalent practical experience
2+ years of one or more general purpose programming languages, including but not limited to: Java, Scala, Python, Go, JavaScript/TypeScript
Full-stack web applications development
Interest in and ability to learn other programming languages and technologies as needed
Qualified applicants must not require employer sponsored work authorization now or in the future for employment in the United States
Preferred
Fluency in one or more general purpose programming languages including but not limited to: Java, Scala, JavaScript/TypeScript, Python, Go
Experience developing full-stack products is a plus
Experience working within an agile organization (we use Jira extensively)
Demonstrated ability to apply problem-solving skills to complex issues
Demonstrated interest in and ability to learn other programming languages and technologies as needed
Benefits
Bonus
Benefits
Company
Verily
Verily is an Alphabet health tech company focused on research, care, and health financing to deliver on the promise of precision health. It is a sub-organization of Alphabet.
Funding
Current Stage
Late StageTotal Funding
$3.51BKey Investors
Michael J. Fox FoundationSwiss Re Corporate SolutionsSilver Lake
2025-04-30Grant· $14.7M
2022-09-29Secondary Market
2022-09-09Corporate Round· $1B
Recent News
2025-12-15
Dallas Innovates
2025-12-12
Company data provided by crunchbase